Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Medical Holdings Co ( (HK:1515) ) has provided an announcement.
China Resources Medical Holdings Co announced its unaudited consolidated results for the first half of 2025, reporting a decline in revenue and profit compared to the same period in 2024. The company faced a decrease in gross profit and net income, with revenue dropping from RMB 4,976 million to RMB 4,525 million and profit falling from RMB 512 million to RMB 374 million. Despite the challenges, the company managed to increase other income significantly, which partially offset the decline in gross profit. The results indicate a challenging operating environment, impacting the company’s financial performance and potentially influencing its strategic decisions moving forward.
The most recent analyst rating on (HK:1515) stock is a Sell with a HK$3.40 price target. To see the full list of analyst forecasts on China Resources Medical Holdings Co stock, see the HK:1515 Stock Forecast page.
More about China Resources Medical Holdings Co
China Resources Medical Holdings Co is a company operating in the healthcare industry, primarily providing medical services and healthcare management. The company focuses on delivering comprehensive healthcare solutions and services across its network of hospitals and medical facilities.
Average Trading Volume: 11,297,037
Current Market Cap: HK$4.93B
Learn more about 1515 stock on TipRanks’ Stock Analysis page.